Rene Sindlev - 13 Feb 2024 Form 4 Insider Report for RENOVARO BIOSCIENCES INC. (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Issuer symbol
RENB
Transactions as of
13 Feb 2024
Net transactions value
$0
Form type
4
Filing time
15 Feb 2024, 18:38:55 UTC
Previous filing
12 Sep 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Conversion of derivative security +701,260 +5.6% 13,133,598 13 Feb 2024 By RS Bio ApS F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Series A Convertible Preferred Stock Conversion of derivative security $0 -70,126 -100% $0.000000* 0 13 Feb 2024 Common Stock 701,260 $0.000000 By RS Bio ApS F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share.
F2 The Preferred Stock is convertible into Common Stock on a one-for-ten basis.
F3 The Preferred Stock is perpetual and has no expiration date.